Gil Blum
Stock Analyst at Needham
(3.07)
# 1,320
Out of 4,984 analysts
413
Total ratings
37.85%
Success rate
2.86%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Gil Blum
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RXRX Recursion Pharmaceuticals | Reiterates: Buy | $8 | $4.71 | +69.85% | 25 | Sep 11, 2025 | |
| CELC Celcuity | Maintains: Buy | $74 → $70 | $54.60 | +28.21% | 19 | Aug 15, 2025 | |
| ABSI Absci | Maintains: Buy | $9 → $8 | $2.55 | +213.73% | 5 | Aug 13, 2025 | |
| AUTL Autolus Therapeutics | Reiterates: Buy | $10 | $1.27 | +687.40% | 29 | Jul 21, 2025 | |
| CRSP CRISPR Therapeutics AG | Reiterates: Buy | $81 | $59.07 | +37.13% | 24 | Jul 8, 2025 | |
| ARTV Artiva Biotherapeutics | Maintains: Buy | $23 → $18 | $2.28 | +689.47% | 6 | May 15, 2025 | |
| ACLX Arcellx | Reiterates: Buy | $105 | $76.42 | +37.40% | 23 | Dec 10, 2024 | |
| IMAB I-Mab | Reiterates: Buy | $6 | $3.69 | +62.60% | 17 | Sep 8, 2025 | |
| GBIO Generation Bio Co. | Reiterates: Buy | $15 | $5.77 | +159.97% | 18 | Aug 13, 2025 | |
| NKTX Nkarta | Reiterates: Buy | $10 | $1.91 | +423.56% | 18 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Underperform | n/a | $17.05 | - | 38 | Jul 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | n/a | $3.03 | - | 22 | Jul 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $5 | $1.73 | +189.02% | 19 | Jul 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 | $2.90 | +175.86% | 29 | Jul 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $0.95 | - | 8 | Jun 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $41 → $40 | $9.15 | +337.16% | 15 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $27 | $8.57 | +215.05% | 24 | Apr 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $71 | $33.42 | +112.48% | 14 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $9 | $1.60 | +462.50% | 7 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $1.94 | - | 16 | Mar 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $1.27 | +293.70% | 22 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $7.97 | - | 6 | Feb 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $48 | $5.55 | +764.86% | 9 | Aug 2, 2024 |
Recursion Pharmaceuticals
Sep 11, 2025
Reiterates: Buy
Price Target: $8
Current: $4.71
Upside: +69.85%
Celcuity
Aug 15, 2025
Maintains: Buy
Price Target: $74 → $70
Current: $54.60
Upside: +28.21%
Absci
Aug 13, 2025
Maintains: Buy
Price Target: $9 → $8
Current: $2.55
Upside: +213.73%
Autolus Therapeutics
Jul 21, 2025
Reiterates: Buy
Price Target: $10
Current: $1.27
Upside: +687.40%
CRISPR Therapeutics AG
Jul 8, 2025
Reiterates: Buy
Price Target: $81
Current: $59.07
Upside: +37.13%
Artiva Biotherapeutics
May 15, 2025
Maintains: Buy
Price Target: $23 → $18
Current: $2.28
Upside: +689.47%
Arcellx
Dec 10, 2024
Reiterates: Buy
Price Target: $105
Current: $76.42
Upside: +37.40%
I-Mab
Sep 8, 2025
Reiterates: Buy
Price Target: $6
Current: $3.69
Upside: +62.60%
Generation Bio Co.
Aug 13, 2025
Reiterates: Buy
Price Target: $15
Current: $5.77
Upside: +159.97%
Nkarta
Aug 13, 2025
Reiterates: Buy
Price Target: $10
Current: $1.91
Upside: +423.56%
Jul 29, 2025
Reiterates: Underperform
Price Target: n/a
Current: $17.05
Upside: -
Jul 24, 2025
Maintains: Hold
Price Target: n/a
Current: $3.03
Upside: -
Jul 10, 2025
Maintains: Buy
Price Target: $7 → $5
Current: $1.73
Upside: +189.02%
Jul 1, 2025
Reiterates: Buy
Price Target: $8
Current: $2.90
Upside: +175.86%
Jun 12, 2025
Reiterates: Hold
Price Target: n/a
Current: $0.95
Upside: -
May 8, 2025
Maintains: Buy
Price Target: $41 → $40
Current: $9.15
Upside: +337.16%
Apr 29, 2025
Reiterates: Buy
Price Target: $27
Current: $8.57
Upside: +215.05%
Apr 10, 2025
Reiterates: Buy
Price Target: $71
Current: $33.42
Upside: +112.48%
Apr 8, 2025
Reiterates: Buy
Price Target: $9
Current: $1.60
Upside: +462.50%
Mar 27, 2025
Reiterates: Hold
Price Target: n/a
Current: $1.94
Upside: -
Mar 12, 2025
Reiterates: Buy
Price Target: $5
Current: $1.27
Upside: +293.70%
Feb 20, 2025
Reiterates: Hold
Price Target: n/a
Current: $7.97
Upside: -
Aug 2, 2024
Reiterates: Buy
Price Target: $48
Current: $5.55
Upside: +764.86%